Parker-Hannifin Corporation PH
Verdict: Sell. Fair value $707 against a price of $913 on 6 Jan 2026, 23% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Macro headwinds could impact growth. Valuation multiple compression risk.
Main risks
- Decelerating revenue growth, with the latest annual figure showing a slight -0.4% decline after a strong multi-year run.
- Moderate leverage with an estimated Net Debt/EBITDA ratio of 2.43x, which warrants monitoring, especially if revenue and earnings trends flatten.
- Significant gaps in historical data (e.g., balance sheet, EBIT) necessitate reliance on proxies, reducing confidence in some metrics like ROIIC.
- Valuation prices in optimistic scenario (limited margin for error)
- Overhang: Significant insider selling (US$18m) suggests internal hesitancy or a belief that the stoc...
- Market volatility